1 month Rigel Pharmaceuticals (NASDAQ:RIGL) Raised to Strong-Buy at StockNews.comMarketBeat
StockNews.com raised shares of Rigel Pharmaceuticals from a “buy” rating to a “strong-buy” rating in a research note on Friday.
Nasdaq 100 · Pharmaceuticals · Science
X